These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27942451)

  • 81. Structural brain correlates of dementia in Huntington's disease.
    Martinez-Horta S; Sampedro F; Horta-Barba A; Perez-Perez J; Pagonabarraga J; Gomez-Anson B; Kulisevsky J
    Neuroimage Clin; 2020; 28():102415. PubMed ID: 32979842
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Brain MRI morphometric analysis in Parkinson's disease patients with sleep disturbances.
    Radziunas A; Deltuva VP; Tamasauskas A; Gleizniene R; Pranckeviciene A; Petrikonis K; Bunevicius A
    BMC Neurol; 2018 Jun; 18(1):88. PubMed ID: 29925331
    [TBL] [Abstract][Full Text] [Related]  

  • 83. White and Gray Matter Volume Changes and Correlation with Visual Evoked Potential in Patients with Optic Neuritis: A Voxel-Based Morphometry Study.
    Huang X; Zhang Q; Hu PH; Zhong YL; Zhang Y; Wei R; Xu TT; Shao Y;
    Med Sci Monit; 2016 Apr; 22():1115-23. PubMed ID: 27045330
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Patterns of regional gray matter and white matter atrophy in cortical multiple sclerosis.
    Parisi L; Rocca MA; Mattioli F; Riccitelli GC; Capra R; Stampatori C; Bellomi F; Filippi M
    J Neurol; 2014 Sep; 261(9):1715-25. PubMed ID: 24952616
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease.
    Minkova L; Gregory S; Scahill RI; Abdulkadir A; Kaller CP; Peter J; Long JD; Stout JC; Reilmann R; Roos RA; Durr A; Leavitt BR; Tabrizi SJ; Klöppel S;
    Neuroimage Clin; 2018; 17():312-324. PubMed ID: 29527479
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
    Reetz K; Costa AS; Mirzazade S; Lehmann A; Juzek A; Rakowicz M; Boguslawska R; Schöls L; Linnemann C; Mariotti C; Grisoli M; Dürr A; van de Warrenburg BP; Timmann D; Pandolfo M; Bauer P; Jacobi H; Hauser TK; Klockgether T; Schulz JB;
    Brain; 2013 Mar; 136(Pt 3):905-17. PubMed ID: 23423669
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Longitudinal patterns of leukoaraiosis and brain atrophy in symptomatic small vessel disease.
    Lambert C; Benjamin P; Zeestraten E; Lawrence AJ; Barrick TR; Markus HS
    Brain; 2016 Apr; 139(Pt 4):1136-51. PubMed ID: 26936939
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Identifying brain changes related to cognitive aging using VBM and visual rating scales.
    Pergher V; Demaerel P; Soenen O; Saarela C; Tournoy J; Schoenmakers B; Karrasch M; Van Hulle MM
    Neuroimage Clin; 2019; 22():101697. PubMed ID: 30739844
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Bariatric Surgery Induces White and Grey Matter Density Recovery in the Morbidly Obese: A Voxel-Based Morphometric Study.
    Tuulari JJ; Karlsson HK; Antikainen O; Hirvonen J; Pham T; Salminen P; Helmiö M; Parkkola R; Nuutila P; Nummenmaa L
    Hum Brain Mapp; 2016 Nov; 37(11):3745-3756. PubMed ID: 27400738
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Selective vulnerability to atrophy in sporadic Creutzfeldt-Jakob disease.
    Younes K; Rojas JC; Wolf A; Sheng-Yang GM; Paoletti M; Toller G; Caverzasi E; Luisa Mandelli M; Illán-Gala I; Kramer JH; Cobigo Y; Miller BL; Rosen HJ; Geschwind MD
    Ann Clin Transl Neurol; 2021 Jun; 8(6):1183-1199. PubMed ID: 33949799
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Longitudinal Study of Gray Matter Changes in Parkinson Disease.
    Jia X; Liang P; Li Y; Shi L; Wang D; Li K
    AJNR Am J Neuroradiol; 2015 Dec; 36(12):2219-26. PubMed ID: 26359153
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Prion disease diagnosis using subject-specific imaging biomarkers within a multi-kernel Gaussian process.
    Canas LS; Sudre CH; De Vita E; Nihat A; Mok TH; Slattery CF; Paterson RW; Foulkes AJM; Hyare H; Cardoso MJ; Thornton J; Schott JM; Barkhof F; Collinge J; Ourselin S; Mead S; Modat M
    Neuroimage Clin; 2019; 24():102051. PubMed ID: 31734530
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Distinct Patterns of Brain Atrophy associated with Mild Behavioral Impairment in Cognitively Normal Elderly Adults.
    Shu J; Qiang Q; Yan Y; Wen Y; Ren Y; Wei W; Zhang L
    Int J Med Sci; 2021; 18(13):2950-2956. PubMed ID: 34220322
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Progressive brain structural changes after the first year of treatment in first-episode treatment-naive patients with deficit or nondeficit schizophrenia.
    Lei W; Kirkpatrick B; Wang Q; Deng W; Li M; Guo W; Liang S; Li Y; Zhang C; Li X; Zhang P; Li Z; Xiang B; Chen J; Hu X; Zhang N; Li T
    Psychiatry Res Neuroimaging; 2019 Jun; 288():12-20. PubMed ID: 31059954
    [TBL] [Abstract][Full Text] [Related]  

  • 95. APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia.
    Vipin A; Kumar D; Soo SA; Zailan FZ; Leow YJ; Koh CL; Ng ASL; Ng KP; Kandiah N
    Alzheimers Res Ther; 2023 Jun; 15(1):103. PubMed ID: 37270543
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Clinical and MRI correlates of disease progression in a case of nonfluent/agrammatic variant of primary progressive aphasia due to progranulin (GRN) Cys157LysfsX97 mutation.
    Caso F; Agosta F; Magnani G; Galantucci S; Spinelli EG; Galimberti D; Falini A; Comi G; Filippi M
    J Neurol Sci; 2014 Jul; 342(1-2):167-72. PubMed ID: 24814951
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Longitudinal changes of deep gray matter shape in multiple sclerosis.
    Tsagkas C; Geiter E; Gaetano L; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Kappos L; Sprenger T; Granziera C; Mallar Chakravarty M; Magon S
    Neuroimage Clin; 2022; 35():103137. PubMed ID: 36002960
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Comparison of grey matter volume and thickness for analysing cortical changes in chronic schizophrenia: a matter of surface area, grey/white matter intensity contrast, and curvature.
    Kong L; Herold CJ; Zöllner F; Salat DH; Lässer MM; Schmid LA; Fellhauer I; Thomann PA; Essig M; Schad LR; Erickson KI; Schröder J
    Psychiatry Res; 2015 Feb; 231(2):176-83. PubMed ID: 25595222
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A multiparametric MRI study of structural brain damage in dementia with lewy bodies: A comparison with Alzheimer's disease.
    Caso F; Agosta F; Scamarcia PG; Basaia S; Canu E; Magnani G; Volontè MA; Filippi M
    Parkinsonism Relat Disord; 2021 Oct; 91():154-161. PubMed ID: 34628194
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Multimodal MRI of grey matter, white matter, and functional connectivity in cognitively healthy mutation carriers at risk for frontotemporal dementia and Alzheimer's disease.
    Feis RA; Bouts MJRJ; Dopper EGP; Filippini N; Heise V; Trachtenberg AJ; van Swieten JC; van Buchem MA; van der Grond J; Mackay CE; Rombouts SARB
    BMC Neurol; 2019 Dec; 19(1):343. PubMed ID: 31881858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.